- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: (PARP) Inhibitors
Total 64228 results
-
University of OklahomaGlaxoSmithKlineTerminatedRecurrent Glioblastoma | Recurrent Glioma | Recurrent Astrocytoma | Recurrent OligodendrogliomaUnited States
-
Tianjin Medical University Second HospitalUnknown
-
Tesaro, Inc.Completed
-
University College, LondonMedivation, Inc.WithdrawnEndometrial CancerUnited Kingdom
-
University Hospital, CaenCompleted
-
Lisette NixonAstraZenecaUnknownNon-small Cell Lung CancerUnited Kingdom
-
Massachusetts General HospitalUniversity of Pennsylvania; Duke University; Sibley Memorial HospitalRecruitingBreast Cancer | Triple Negative Breast CancerUnited States
-
University of Michigan Rogel Cancer CenterActive, not recruitingProstate CancerUnited States
-
Genentech, Inc.Terminated
-
Nerviano Medical SciencesRecruitingGlioblastoma | Diffuse GliomaSwitzerland, United States, Netherlands, Italy
-
The University of Hong KongRecruitingEndometrial CancerHong Kong
-
Peter MacCallum Cancer Centre, AustraliaRecruitingNeuroendocrine TumorsAustralia
-
Tesaro, Inc.Merck Sharp & Dohme LLCCompletedNeoplasms | Breast Cancer | Advanced Breast Cancer | Ovarian Cancer | Fallopian Tube Cancer | Metastatic Breast Cancer | Triple Negative Breast Cancer | Peritoneal Cancer | Stage IV Breast CancerUnited States
-
PfizerCompleted
-
National Cancer Institute (NCI)RecruitingPancreatic Acinar Cell Carcinoma | Pancreatic Adenosquamous Carcinoma | Pancreatic Squamous Cell Carcinoma | Resectable Pancreatic Acinar Cell Carcinoma | Resectable Pancreatic Adenocarcinoma | Resectable Pancreatic Adenosquamous Carcinoma | Resectable Pancreatic CarcinomaUnited States
-
Jun GuoNot yet recruiting
-
AstraZenecaMerck Sharp & Dohme LLC; European Network of Gynaecological Oncological Trial... and other collaboratorsActive, not recruitingRelapsed Ovarian Cancer | Following Complete or Partial Response to Platinum Based Chemotherapy | Platinum Sensitive | BRCA MutatedKorea, Republic of, France, China, Italy, United States, Israel, United Kingdom, Canada, Japan, Germany, Brazil, Netherlands, Belgium, Poland, Australia, Russian Federation, Spain
-
Jonsson Comprehensive Cancer CenterTesaro, Inc.; Translational Research in Oncology-U.SRecruitingStage IVA Lung Cancer AJCC v8 | Stage IVB Lung Cancer AJCC v8 | Advanced Malignant Solid Neoplasm | Stage III Lung Cancer AJCC v8 | Stage IV Lung Cancer AJCC v8 | Stage IIIA Lung Cancer AJCC v8 | Stage IIIB Lung Cancer AJCC v8 | Extensive Stage Lung Small Cell Carcinoma | Stage IIIC Lung Cancer AJCC v8United States
-
Vejle HospitalAbbottCompletedRecurrent, Epithelial Ovarian CancerDenmark
-
Jiangsu HengRui Medicine Co., Ltd.The Affiliated Hospital of the Chinese Academy of Military Medical SciencesUnknownRecurrent and Metastatic Gastric CancerChina
-
PfizerTerminatedOvarian CancerKorea, Republic of, United States, Singapore, Taiwan, Japan, Italy, Australia, Belgium, Ireland, Russian Federation
-
Sidney Kimmel Comprehensive Cancer Center at Johns...National Cancer Institute (NCI); BeiGeneCompletedRecurrent Glioblastoma | Recurrent WHO Grade III Glioma | Recurrent WHO Grade II Glioma | IDH1 Mutation | IDH2 MutationUnited States
-
Ruijin HospitalRecruitingSarcoma | Sarcoma,Soft Tissue | Sarcoma of BoneChina
-
Sarah E TaylorAmerican Society of Clinical OncologyTerminatedOvarian CancerUnited States
-
zr Pharma & GmbHBristol-Myers Squibb; Foundation MedicineTerminatedFallopian Tube Cancer | Epithelial Ovarian Cancer | Endometrioid Adenocarcinoma | High Grade Serous Carcinoma | Primary Peritoneal CarcinomaUnited States
-
Chongqing University Cancer HospitalRecruiting
-
California Pacific Medical Center Research InstituteTesaro, Inc.; Vanderbilt-Ingram Cancer Center; Huntsman Cancer InstituteRecruitingMetastatic MelanomaUnited States
-
PfizerTerminatedAvelumab in Combination With Talazoparib Will be Investigated in Patients With Locally Advanced (Primary or Recurrent) or Metastatic Solid TumorsUnited States, Canada, United Kingdom, Korea, Republic of, Australia, Belgium, Denmark, Hungary, Russian Federation
-
Hellenic Cooperative Oncology GroupActive, not recruitingOvarian CancerGreece
-
Institute of Cancer Research, United KingdomRoyal Marsden NHS Foundation TrustNot yet recruitingOvarian Cancer RecurrentUnited Kingdom
-
Novartis PharmaceuticalsCompletedSolid Tumors | LymphomasSpain, Canada, Singapore, Israel, Japan, United States
-
Guangxi Medical UniversityNot yet recruitingOvarian Cancer | Fallopian Tube Cancer | Primary Peritoneal Carcinoma | High Grade Serous Adenocarcinoma of OvaryChina
-
PfizerMedivation, Inc.CompletedAcute Myeloid Leukemia | Mantle Cell Lymphoma | Chronic Lymphocytic Leukemia | Myelodysplastic SyndromeUnited Kingdom, United States
-
PfizerMedivation, Inc.CompletedBreast Neoplasms | BRCA 1 Gene Mutation | BRCA 2 Gene MutationKorea, Republic of, United States, Australia, Spain, Belgium, France, Ireland, Taiwan, Poland, Germany, Israel, Brazil, United Kingdom, Italy, Russian Federation, Ukraine
-
PfizerMedivation, Inc.; Myriad Genetic Laboratories, Inc.TerminatedBreast Neoplasms | BRCA 1 Gene Mutation | BRCA 2 Gene MutationUnited States, Spain, United Kingdom, Germany, France
-
Haider MahdiPfizer; Zenith EpigeneticsRecruitingOvarian Cancer | Fallopian Tube Cancer | Peritoneal CancerUnited States
-
University of ArizonaActive, not recruiting
-
Zhonglin HaoClovis Oncology, Inc.Active, not recruitingSmall Cell Lung CancerUnited States
-
Nordic Society of Gynaecological Oncology - Clinical...Massachusetts General Hospital; University of Utah; European Network of Gynaecological... and other collaboratorsCompletedOvarian CancerUnited States, Denmark
-
National Cancer Institute (NCI)RecruitingBreast Neoplasms | Colorectal NeoplasmsUnited States
-
Fudan UniversityChongqing University Cancer Hospital; Sun Yat-sen University; Peking University... and other collaboratorsRecruitingBreast Cancer MetastaticChina
-
Assistance Publique - Hôpitaux de ParisNot yet recruitingMetastatic Breast Cancer in Germline-PALB2 Mutations Carriers
-
Chongqing University Cancer HospitalNot yet recruitingPARP Inhibitor for Esophageal Squamous Cell Carcinoma
-
National Cancer Institute (NCI)Completed
-
Sun Yat-sen UniversityHutchmedRecruitingOvarian Cancer | Platinum-resistant Ovarian Cancer | Primary Peritoneal Cancer | Ovarian Carcinoma | Fallopian Tube CarcinosarcomaChina
-
Fondazione Policlinico Universitario Agostino Gemelli...RecruitingBRCA-Associated Breast CarcinomaItaly
-
Abramson Cancer Center at Penn MedicineActive, not recruitingProstate CancerUnited States
-
Cellceutix CorporationDana-Farber Cancer Institute; Beth Israel Deaconess Medical CenterCompletedSolid TumorsUnited States
-
PfizerMedivation, Inc.CompletedBreast Neoplasms | Small Cell Lung Carcinoma | Prostate Cancer | Ewing Sarcoma | Pancreas Cancer | Ovarian Cancer, Epithelial | Advanced or Recurrent Solid TumorsUnited States, United Kingdom
-
Leiden University Medical CenterRadboud University Medical Center; AstraZeneca; University Medical Center Groningen and other collaboratorsActive, not recruitingUterine Neoplasms | Endometrial Neoplasms | Endometrium CancerNetherlands